Here are the four ASC administrators named Administrator of the Week by Becker’s in November:
Category: ROOT
Viewpoint: healthcare workers face 'moral injury,' not just burnout
The term “burnout” understates the struggles of healthcare professionals — “moral injury” is a more accurate attribution, psychologist Jessica Jackson, PhD, wrote in a Dec. 3 article for Quartz.
Lehigh Valley breaks ground on new $27M hospital construction project
Construction started on the $27 million Lehigh Valley Hospital-Macungie project, which is slated to include a 22,194-square-foot hospital and a 10,182-square-foot office building, The Morning Call reported Dec. 5.
West Virginia hospital evacuates after bomb threat
Madison, W.Va.-based Boone Memorial Hospital was evacuated following a bomb threat on the evening of Dec. 4.
Baltimore Lions Club donates $8K to research center, Johns Hopkins eye institute
A branch of the Lord Baltimore Lions Club has made a donation to the Lions Vision Research Center and The Johns Hopkins’ Wilmer Eye Institute, both in Baltimore, the Cape Gazette reported Dec. 3.
Virginia children's health system CEO sets retirement; leadership shuffle ensues
James Dahling, president and CEO of Hampton Roads, Va.-based Children’s Hospital of the King’s Daughters, will retire in 2023 after nearly 20 years in the role.
Endoluxe, Mayo Clinic partner on AI research
Imaging company Endoluxe has entered into a know-how agreement with Rochester, Minn.- based Mayo Clinic to research the uses of artificial intelligence and machine learning in the treatment of bladder cancer.
Associated Eye Care to move into Wisconsin medical center
Stillwater, Minn.-based Associated Eye Care will move to Hudson (Wis.) Medical Center in a three-story building with other businesses, the Star Observer reported Dec. 2.
Delayed Virginia psychiatric hospital facing $50M cost increase
Replacing Virginia’s Central State Hospital could cost up to $400 million, approximately $50 million higher than current estimates, the Richmond Times-Dispatch reported Nov. 27.
Drugmaker didn't expect weight-loss drugs to go viral as supply flounders
Denmark-based Novo Nordisk wasn’t prepared for Wegovy and Ozempic — which are approved for weight-loss and diabetes, respectively — to go viral, The Wall Street Journal reported Dec. 4.
